Products

Primary tabs

Export products to Excel

Displaying 1 - 9 of 9
Target: Female
Mode: Hormonal
Delivery Type: Subdermal
Project Stage: Pre-clinical
Partner: Bayer HealthCare
Alternative Name: FC-Patch low, Lisvy®
Development Status: SRA/WHO PQ Approved
Target: Female
Mode: Hormonal
Delivery Type: Transdermal
Project Stage: Regulatory
Development Status: Inactive
Target: Female
Mode: Hormonal
Delivery Type: Injectable
Partner: Bayer HealthCare
Alternative Name: LNG Contraceptive IUS (LCS), LCS16
Development Status: SRA/WHO PQ Approved
Target: Female
Mode: Hormonal
Delivery Type: Intrauterine
Project Stage: Marketed
Partner: Bayer HealthCare
Alternative Name: Oil-based drospirenone (DSRP) microcrystal suspension
Development Status: Inactive
Target: Female
Mode: Hormonal
Delivery Type: Injectable
Project Stage: Pre-clinical
Partner: Bayer HealthCare
Alternative Name: Prostaglandin E2 (PGE2) Synthesis / Signaling inhibitors
Development Status: Active Development
Target: Female
Mode: Non-hormonal
Delivery Type: TBD
Project Stage: Target ID/Validation
Alternative Name: TU, Aveed
Development Status: Inactive
Target: Male
Mode: Hormonal
Delivery Type: Injectable
Project Stage: Phase III
Alternative Name: Testosterone undecanoate (TU) + norethisterone enanthate (NET-EN
Development Status: Inactive
Target: Male
Mode: Hormonal
Delivery Type: Injectable
Project Stage: Phase II
Alternative Name: LNG Contraceptive IUS 12 (LCS12)
Development Status: Active Development
Target: Female
Mode: Hormonal
Delivery Type: Intrauterine
Project Stage: Regulatory
Partner: Bayer HealthCare
Export to Excel